6833 — Sinco Pharmaceuticals Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual balance sheet for Sinco Pharmaceuticals Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	222	144	326	329	438
Net Total Accounts Receivable
Net Total Receivables	57.8	588	225	390	541
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	626	1,006	969	1,017	1,433
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	198	238	256	316	354
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	832	1,252	1,233	1,424	1,891
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	656	991	726	791	1,232
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	785	1,087	858	821	1,263
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	47.2	165	375	604	628
Total Liabilities & Shareholders' Equity	832	1,252	1,233	1,424	1,891
Total Common Shares Outstanding